Publikationen von Jung, Andreas

Zur erweiterten Suche

Eine Ebene nach oben

Gruppiert nach: Dokumententyp | Veröffentlichungsdatum

Springe zu: Zeitschriftenartikel

Anzahl der Publikationen: 77

Zeitschriftenartikel

Jaitner, Stefanie; Pretzsch, Elise; Neumann, Jens; Schäffauer, Achim; Schiemann, Matthias; Angele, Martin; Kumbrink, Jörg; Schwitalla, Sarah; Greten, Florian R; Brandl, Lydia; Klauschen, Frederick; Horst, David; Kirchner, Thomas und Jung, Andreas (8. November 2022): Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer. In: The Journal of Pathology: Clinical Research, Bd. 9, Nr. 1: S. 73-85 [PDF, 1MB]

Sellmer, Laura; Kovács, Julia; Walter, Julia; Kumbrink, Jörg; Neumann, Jens; Kauffmann-Guerrero, Diego; Kiefl, Rosemarie; Schneider, Christian; Jung, Andreas; Behr, Jürgen und Tufman, Amanda (27. Juni 2022): Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC. In: Frontiers in Immunology, Bd. 13 [PDF, 1MB]

Fischer, Laura E.; Stintzing, Sebastian; Heinemann, Volker; Keilholz, Ulrich; Keune, Dietmar; Vollbrecht, Claudia; Burmeister, Thomas; Kind, Andreas; Weiss, Lena; Horst, David; Kirchner, Thomas; Klauschen, Frederick; Jung, Andreas; Westphalen, Christoph Benedikt und Jelas, Ivan (2022): Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers. In: Frontiers in Oncology, Bd. 12, 870411

Heinrich, Kathrin; Miller-Phillips, Lisa; Ziemann, Frank; Hasselmann, Korbinian; Rühlmann, Katharina; Flach, Madeleine; Biro, Dorottya; Bergwelt-Baildon, Michael von; Holch, Julian; Herold, Tobias; Baumgarten, Louisa von; Greif, Philip A.

; Jeremias, Irmela; Wuerstlein, Rachel; Casuscelli, Jozefina; Spitzweg, Christine; Seidensticker, Max; Renz, Bernhard; Corradini, Stefanie; Baumeister, Philipp; Goni, Elisabetta; Tufman, Amanda; Jung, Andreas; Kumbrink, Jörg; Kirchner, Thomas; Klauschen, Frederick; Metzeler, Klaus H.; Heinemann, Volker und Westphalen, C. Benedikt

(2022): Lessons learned: the first consecutive 1000 patients of the CCCMunich(LMU) Molecular Tumor Board. In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 5: S. 1905-1915 [PDF, 728kB]

Torlot, Lucien; Jarzab, Anna; Albert, Johanna; Pok-Udvari, Agnes; Stahler, Arndt; Holch, Julian Walter; Gerlinger, Marco; Heinemann, Volker; Klauschen, Frederick; Kirchner, Thomas; Kumbrink, Jörg; Küster, Bernhard und Jung, Andreas

(2022): Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance. In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 2: S. 669-682 [PDF, 2MB]

Fischer, Laura E.

; Stintzing, Sebastian; Weikersthal, Ludwig Fischer von; Modest, Dominik P.; Decker, Thomas; Kiani, Alexander

; Kaiser, Florian; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Giessen-Jung, Clemens; Uhlig, Jens; Peuser, Bettina; Denzlinger, Claudio; Stahler, Arndt; Weiss, Lena; Heinrich, Kathrin; Held, Swantje; Jung, Andreas; Kirchner, Thomas und Heinemann, Volker (2022): Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3. In: British Journal of Cancer, Bd. 127, Nr. 5: S. 836-843 [PDF, 788kB]

Flach, Susanne; Kumbrink, Jörg; Walz, Christoph; Hess, Julia; Drexler, Guido; Belka, Claus; Canis, Martin; Jung, Andreas und Baumeister, Philipp (2022): Analysis of genetic variants of frequently mutated genes in human papillomavirus-negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell-free DNA. In: Journal of Oral Pathology & Medicine, Bd. 51, Nr. 8: S. 738-746 [PDF, 1MB]

Käsmann, Lukas; Taugner, Julian; Eze, Chukwuka; Nieto, Alexander; Pelikan, Carolyn; Flörsch, Benedikt; Kenndoff, Saskia; Hofer, Thomas P.; Nössner, Elfriede; Schulz, Christian; Unterrainer, Marcus; Tufman, Amanda; Klauschen, Frederick; Jung, Andreas; Neumann, Jens; Kumbrink, Jorg; Reinmuth, Niels; Bartenstein, Peter; Belka, Claus und Manapov, Farkhad (2022): Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study. In: Translational Lung Cancer Research, Bd. 11, Nr. 7: S. 1503-1509 [PDF, 294kB]

Kumbrink, Jorg; Bohlmann, Lisa; Mamlouk, Soulafa; Redmer, Torben; Peilstocker, Daniela; Li, Pan; Lorenzen, Sylvie; Alguel, Hana; Kasper, Stefan; Hempel, Dirk; Kaiser, Florian; Michl, Marlies; Bartsch, Harald; Neumann, Jens; Klauschen, Frederick; Bergwelt-Baildon, Michael von; Modest, Dominik Paul; Stahler, Arndt; Stintzing, Sebastian; Jung, Andreas; Kirchner, Thomas; Schäfer, Reinhold; Heinemann, Volker und Holch, Julian W. (2022): Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL. In: Cancers, Bd. 14, Nr. 15 [PDF, 4MB]

Vollbrecht, Claudia; Hoffmann, Inga; Lehmann, Annika; Merkelbach-Bruse, Sabine; Fassunke, Jana; Wagener-Ryczek, Svenja; Ball, Markus; Dimitrova, Lora; Hartmann, Arndt; Stohr, Robert; Erber, Ramona; Weichert, Wilko; Pfarr, Nicole; Bohlmann, Lisa; Jung, Andreas; Dietmaier, Wolfgang; Dietel, Manfred; Horst, David und Hummel, Michael (2022): Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue. In: Virchows Archiv, Bd. 482, Nr. 4: S. 697-706

Stahler, Arndt; Modest, Dominik P.; Fischer von Weikersthal, Ludwig; Kaiser, Florian; Decker, Thomas; Held, Swantje; Graeven, Ullrich; Schwaner, Ingo; Denzlinger, Claudio; Schenk, Michael; Kurreck, Annika; Heinrich, Kathrin; Giessen-Jung, Clemens; Neumann, Jens; Kirchner, Thomas; Jung, Andreas; Stintzing, Sebastian und Heinemann, Volker (2022): First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer - Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110). In: European Journal of Cancer, Bd. 173: S. 194-203

Boos, Sophie L.; Loevenich, Leon P.; Vosberg, Sebastian; Engleitner, Thomas; Öllinger, Rupert; Kumbrink, Joerg; Rokavec, Matjaz; Michl, Marlies; Greif, Philipp A.; Jung, Andreas; Hermeking, Heiko; Neumann, Jens; Kirchner, Thomas; Rad, Roland und Jung, Peter (2022): Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer. In: Cellular and Molecular Gastroenterology and Hepatology, Bd. 13, Nr. 2: S. 517-540

Niedermeyer, Sebastian; Draenert, Rika; Beck, Alexander; Todorova, Rumyana; Jung, Andreas; Biczok, Anna-Maria; Tonn, Jörg-Christian und Thorsteinsdottir, Jun (2022): Spinal Tuberculosis within the Vertebral Arch Mimicking a Malignant Tumor: Case Report. In: Journal of Neurological Surgery Part A: Central European Neurosurgery, Bd. 84, Nr. 1: S. 91-94

Sultova, Elena; Westphalen, C. Benedikt; Jung, Andreas; Kumbrink, Joerg; Kirchner, Thomas; Mayr, Doris; Rudelius, Martina; Ormanns, Steffen; Heinemann, Volker; Metzeler, Klaus H.; Greif, Philipp A.; Burges, Alexander; Trillsch, Fabian; Mahner, Sven; Harbeck, Nadia und Wuerstlein, Rachel (2021): NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU. In: Archives of gynecology and obstetrics, Bd. 303, Nr. 5: S. 1331-1345 [PDF, 1MB]

Vangala, Deepak; Ladigan, Swetlana; Liffers, Sven-Thorsten; Noseir, Soha; Maghnouj, Abdelouahid; Götze, Tina-Maria; Verdoodt, Berlinda; Klein-Scory, Susanne; Godfrey, Laura; Zowada, Martina K.; Huerta, Mario; Edelstein, Daniel L.; Villarreal, Jaime Martinez de; Marqués, Miriam; Kumbrink, Jörg; Jung, Andreas; Schiergens, Tobias S.; Werner, Jens; Heinemann, Volker; Stintzing, Sebastian; Lindoerfer, Doris

; Mansmann, Ulrich; Pohl, Michael; Teschendorf, Christian; Bernhardt, Christiane; Wolters, Heiner; Stern, Josef; Usta, Selami; Viebahn, Richard; Admard, Jacob; Casadei, Nicolas; Fröhling, Stefan; Ball, Claudia R.; Siveke, Jens T.; Glimm, Hanno; Tannapfel, Andrea; Schmiegel, Wolff und Hahn, Stephan A. (2021): Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models. In: Genome Medicine, Bd. 13, Nr. 116 [PDF, 4MB]

Heinrich, Kathrin; Modest, Dominik P.; Ricard, Ingrid; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kaiser, Florian; Graeven, Ullrich; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Giessen-Jung, Clemens; Stahler, Arndt; Michl, Marlies; Held, Swantje; Jung, Andreas; Kirchner, Thomas; Stintzing, Sebastian und Heinemann, Volker (2021): Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110). In: European Journal of Cancer, Bd. 147: S. 128-139

Heydt, Carina; Woelwer, Christina B.; Camacho, Oscar Velazquez; Wagener-Ryczek, Svenja; Pappesch, Roberto; Siemanowski, Janna; Rehker, Jan; Haller, Florian; Agaimy, Abbas; Worm, Karl; Herold, Thomas; Pfarr, Nicole; Weichert, Wilko; Kirchner, Thomas; Jung, Andreas; Kumbrink, Joerg; Goering, Wolfgang; Esposito, Irene; Buettner, Reinhard; Hillmer, Axel M. und Merkelbach-Bruse, Sabine (2021): Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation. In: Springer Nature Medical Genomics, Bd. 14, Nr. 1, 62

Kumbrink, Jörg; Li, Pan; Pok-Udvari, Agnes; Klauschen, Frederick; Kirchner, Thomas und Jung, Andreas (2021): p130Cas Is Correlated with EREG Expression and a Prognostic Factor Depending on Colorectal Cancer Stage and Localization Reducing FOLFIRI Efficacy. In: International Journal of Molecular Sciences, Bd. 22, Nr. 22, 12364

Lehmann, Ulrich und Jung, Andreas (2021): Next Generation Sequencing in der Pathologie. Anwendungen und methodische Herausforderungen. In: Pathologe, Bd. 42, Nr. 4: S. 363-368

Stahler, Arndt; Heinemann, Volker; Schuster, Veronika; Heinrich, Kathrin; Kurreck, Annika; Giessen-Jung, Clemens; Weikersthal, Ludwig Fischer von; Kaiser, Florian; Decker, Thomas; Held, Swantje; Graeven, Ullrich; Schwaner, Ingo; Denzlinger, Claudio; Schenk, Michael; Neumann, Jens; Kirchner, Thomas; Jung, Andreas; Kumbrink, Jorg; Stintzing, Sebastian und Modest, Dominik P. (2021): Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial). In: European Journal of Cancer, Bd. 157: S. 71-80

Sultova, Elena; Westphalen, C. Benedikt; Jung, Andreas; Kumbrink, Jörg; Kirchner, Thomas; Mayr, Doris; Rudelius, Martina; Ormanns, Steffen; Heinemann, Volker; Metzeler, Klaus H.; Greif, Philipp A.; Hester, Anna; Mahner, Sven; Harbeck, Nadia und Würstlein, Rachel (2021): Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting. In: Diagnostics, Bd. 11, Nr. 4, 733

Tufman, Amanda; Neumann, Jens; Manapov, Farkhad; Sellmer, Laura; Jung, Andreas; Kauffmann-Guerrero, Diego; Kahnert, Kathrin; Mertsch, Pontus; Borgmeier, Astrid; Semrau, Sabine; Rittmeyer, Achim; Ulm, Bernhard; Ulm, Kurt; Flentje, Michael; Fietkau, Rainer und Huber, Rudolf Maria (2021): Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT). In: Lung Cancer, Bd. 160: S. 17-27

Vangala, Deepak; Ladigan, Swetlana; Liffers, Sven T.; Noseir, Soha; Maghnouj, Abdelouahid; Gotze, Tina-Maria; Verdoodt, Berlinda; Klein-Scory, Susanne; Godfrey, Laura; Zowada, Martina K.; Huerta, Mario; Edelstein, Daniel L.; de Villarreal, Jaime Martinez; Marques, Miriam; Kumbrink, Jorg; Jung, Andreas; Schiergens, Tobias; Werner, Jens; Heinemann, Volker; Stintzing, Sebastian; Lindoerfer, Doris; Mansmann, Ulrich; Pohl, Michael; Teschendorf, Christian; Bernhardt, Christiane; Wolters, Heiner; Stern, Josef; Usta, Selami; Viebahn, Richard; Admard, Jacob; Casadei, Nicolas; Frohling, Stefan; Ball, Claudia R.; Siveke, Jens T.; Glimm, Hanno; Tannapfel, Andrea; Schmiegel, Wolff und Hahn, Stephan A. (2021): Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models. In: Genome Medicine, Bd. 13, Nr. 1, 116

Rodler, Severin; Jung, Andreas; Greif, Philipp A.; Ruehlmann, Katharina; Apfelbeck, Maria; Tamalunas, Alexander; Kretschmer, Alexander; Schulz, Gerald B.; Szabados, Bernadett; Stief, Christian; Heinemann, Volker; Westphalen, Christoph B. und Casuscelli, Jozefina (2021): Routine application of next-generation sequencing testing in uro-oncology-Are we ready for the next step of personalised medicine? In: European Journal of Cancer, Bd. 146: S. 1-10

Kurreck, Annika; Heinemann, Volker; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kaiser, Florian; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Graeven, Ullrich; Schwaner, Ingo; Stahler, Arndt; Heinrich, Kathrin; Jung, Andreas; Held, Swantje; von Einem, Jobst C.; Stintzing, Sebastian; Giessen-Jung, Clemens und Modest, Dominik P. (2020): Impact of age on efficacy and early mortality of initial sequential treatment versus upfront combination chemotherapy in patients with metastatic colorectal cancer: a subgroup analysis of a phase III trial (AIO KRK0110, XELAVIRI study). In: European Journal of Cancer, Bd. 137: S. 81-92

Woischke, Christine; Jung, Peter; Jung, Andreas; Kumbrink, Jörg; Eisenlohr, Sibylle; Auernhammer, Christoph Josef; Vieth, Michael; Kirchner, Thomas und Neumann, Jens (2020): Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity. In: Journal of Pathology Clinical Research, Bd. 7, Nr. 1: S. 75-85 [PDF, 1MB]

Kirchner, Martina; Glade, Julia; Lehmann, Ulrich; Merkelbach-Bruse, Sabine; Hummel, Michael; Lehmann, Annika; Trautmann, Marcel; Kumbrink, Jorg; Jung, Andreas; Dietmaier, Wolfgang; Endris, Volker; Kazdal, Daniel; Ploeger, Carolin; Evert, Matthias; Horst, David; Kreipe, Hans; Kirchner, Thomas; Wardelmann, Eva; Buettner, Reinhard; Weichert, Wilko; Dietel, Manfred; Schirmacher, Peter; Stenzinger, Albrecht und Pfarr, Nicole (2020): NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays. In: Genes Chromosomes & Cancer, Bd. 59, Nr. 8: S. 445-453

Stahler, Arndt; Stintzing, Sebastian; Einem, Jobst C. von; Westphalen, Christoph B.; Heinrich, Kathrin; Kraemer, Nicole; Michl, Marlies; Modest, Dominik P.; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Moehler, Markus; Kaiser, Florian; Kirchner, Thomas; Jung, Andreas und Heinemann, Volker (2020): Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial. In: European Journal of Cancer, Bd. 137: S. 250-259

Stenzinger, Albrecht; Endris, Volker; Budczies, Jan; Merkelbach-Bruse, Sabine; Kazdal, Daniel; Dietmaier, Wolfgang; Pfarr, Nicole; Siebolts, Udo; Hummel, Michael; Herold, Sylvia; Andreas, Johanna; Zoche, Martin; Toegel, Lars; Rempel, Eugen; Maas, Jörg; Merino, Diana; Stewart, Mark; Zaoui, Karim; Schlesner, Matthias; Glimm, Hanno; Froehling, Stefan; Allen, Jeff; Horst, David; Baretton, Gustavo; Wickenhauser, Claudia; Tiemann, Markus; Evert, Matthias; Moch, Holger; Kirchner, Thomas; Buettner, Reinhard; Schirmacher, Peter; Jung, Andreas; Haller, Florian; Weichert, Wilko und Dietel, Manfred (2020): Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study. In: Journal of Thoracic Oncology, Bd. 15, Nr. 7: S. 1177-1189

Heinemann, Volker; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Kaiser, Florian; Al-Batran, Salah-Edin; Heintges, Tobias; Lerchenmüller, Christoph; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Moehler, Markus; Scheithauer, Werner; Held, Swantje; Miller-Phillips, Lisa; Modest, Dominik Paul; Jung, Andreas; Kirchner, Thomas und Stintzing, Sebastian (2020): FOLFIRI plus cetuximab or bevacizumab for advanced colorectal cancer: final survival and per-protocol analysis of FIRE-3, a randomised clinical trial. In: British Journal of Cancer, Bd. 124, Nr. 3: S. 587-594

Schulz, Christoph; Heinemann, Volker; Heinrich, Kathrin; Haas, Michael; Holch, Julian W.; Fraccaroli, Alessia; Held, Swantje; Einem, Jobst C.von; Modest, Dominik P.; Fischer von Weikersthal, Ludwig; Kullmann, Frank; Moehler, Markus; Scheithauer, Werner; Jung, Andreas und Stintzing, Sebastian (2020): Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study. In: Anti-Cancer Drugs, Bd. 31, Nr. 8: S. 856-865

Stahler, Arndt; Stintzing, Sebastian; Modest, Dominik P.; Ricard, Ingrid; Giessen-Jung, Clemens; Kapaun, Christine; Ivanova, Boryana; Kaiser, Florian; Fischer von Weikersthal, Ludwig; Moosmann, Nicolas; Schalhorn, Andreas; Stauch, Martina; Kiani, Alexander; Held, Swantje; Decker, Thomas; Moehler, Markus; Neumann, Jens; Kirchner, Thomas; Jung, Andreas und Heinemann, Volker (2020): Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials. In: Clinical Cancer Research, Bd. 26, Nr. 24: S. 6559-6567

Baumgarten, Louisa von; Kumbrink, Jörg; Jung, Andreas; Reischer, Anna; Flach, Madeleine; Liebmann, Sibylle; Metzeler, Klaus H.; Holch, Julian W.; Niyazi, Maximilian; Thon, Niklas; Straube, Andreas; Bergwelt-Baildon, Michael von; Heinemann, Volker; Kirchner, Thomas und Westphalen, Christoph Benedikt (2020): Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy. In: Theranostics, Bd. 10, Nr. 2: S. 856-866

Pfarr, Nicole; Kirchner, Martina; Lehmann, Ulrich; Leichsenring, Jonas; Merkelbach-Bruse, Sabine; Glade, Julia; Hummel, Michael; Stoegbauer, Fabian; Lehmann, Annika; Trautmann, Marcel; Kumbrink, Jörg; Jung, Andreas; Dietmaier, Wolfgang; Endris, Volker; Kazdal, Daniel; Evert, Matthias; Horst, David; Kreipe, Hans; Kirchner, Thomas; Wardelmann, Eva; Lassen, Ulrik; Buettner, Reinhard; Weichert, Wilko; Dietel, Manfred; Schirmacher, Peter und Stenzinger, Albrecht (2019): Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays. In: Genes Chromosomes & Cancer, Bd. 59, Nr. 3: S. 178-188

Laurent-Puig, Pierre; Grisoni, Marie-Lise; Heinemann, Volker; Liebaert, Francois; Neureiter, Daniel; Jung, Andreas; Montestruc, Francois; Gaston-Mathe, Yann; Thiebaut, Raphaeele und Stintzing, Sebastian (2019): Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer. In: Clinical Cancer Research, Bd. 25, Nr. 1: S. 134-141

Modest, Dominik Paul; Fischer von Weikersthal, Ludwig; Decker, Thomas; Vehling-Kaiser, Ursula; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Reddemann, Christina Peveling Genannt; Graeven, Ullrich; Schuch, Gunter; Schwaner, Ingo; Stahler, Arndt; Jung, Andreas; Kirchner, Thomas; Held, Swantje; Stintzing, Sebastian; Giessen-Jung, Clemens und Heinemann, Volker (2019): Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled StudyXELAVIRI (AIO KRK0110). In: Journal of Clinical Oncology, Bd. 37, Nr. 1

Taieb, Julien; Jung, Andreas; Sartore-Bianchi, Andrea; Peeters, Marc; Seligmann, Jenny; Zaanan, Aziz; Burdon, Peter; Montagut, Clara und Laurent-Puig, Pierre (2019): The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer. In: Drugs, Bd. 79, Nr. 13: S. 1375-1394

Noethe-Menchen, Tabea; Wallmeier, Julia; Pennekamp, Petra; Hoeben, Inga M.; Olbrich, Heike; Loges, Niki T.; Raidt, Johanna; Dougherty, Gerard W.; Hjeij, Rim; Dworniczak, Bernd; Omran, Heymut; Amirav, Israel; Biebach, Luisa; Fabricius, Dorit; Griese, Matthias; Grosse-Onnebrink, Jörg; Haeffner, Karsten; Hector, Andreas; Jung, Andreas; Kaiser-Labusch, Petra; Kaiser, Thomas; Kessler, Christina; Kitz, Richard; Knowles, Michael R.; Koerner-Rettberg, Cordula; Kristoffersson, Ulf; Leigh, Margaret W.; Mertsch, Pontus; Mischo, Bernhard; Nielsen, Kim G.; Poeta, Marco; Rietschel, Ernst; Roth, Samra; Santamaria, Francesca; Schmalstieg, Christian; Schmidts, Miriam; Schwarz, Carsten; Schwerk, Nicolaus; Seithe, Horst; Tebbe, Johannes; Werner, Claudius und Zariwala, Maimoona A. (2019): Randomization of Left-Right Asymmetry and Congenital Heart Defects The Role of DNAH5 in Humans and Mice. In: Circulation-Genomic and Precision Medicine, Bd. 12, Nr. 11, e002686

Elmasry, Manal; Brandl, Lydia; Engel, Jutta; Jung, Andreas; Kirchner, Thomas und Horst, David (2019): RBP7 is a clinically prognostic biomarker and linked to tumor invasion and EMT in colon cancer. In: Journal of Cancer, Bd. 10, Nr. 20: S. 4883-4891

Engel, Jutta; Weichert, Wilko; Jung, Andreas; Emeny, Rebecca und Hölzel, Dieter (2019): Lymph node infiltration, parallel metastasis and treatment success in breast cancer. In: The Breast, Bd. 48: S. 1-6

Schmidt, Eva Marina; Lamprecht, Sebastian; Blaj, Cristina; Schaaf, Christian; Krebs, Stefan; Blum, Helmut; Hermeking, Heiko; Jung, Andreas; Kirchner, Thomas und Horst, David (2018): Targeting tumor cell plasticity by combined inhibition of NOT CH and MAPK signaling in colon cancer. In: Journal of Experimental Medicine, Bd. 215, Nr. 6: S. 1693-1708

Günther, Michael; Veninga, Vivien; Kumbrink, Jörg; Haas, Michael; Westphalen, C. Benedikt; Kruger, Stephan; Heinemann, Volker; Kirchner, Thomas; Böck, Stefan; Jung, Andreas und Ormanns, Steffen (2018): POLE gene hotspot mutations in advanced pancreatic cancer. In: Journal of Cancer Research and Clinical Oncology, Bd. 144, Nr. 11: S. 2161-2166

Kauffmann-Guerrero, Diego; Huber, Rudolf Maria; Reu, Simone; Tufman, Amanda; Mertsch, Pontus; Syunyaeva, Zulfiya; Jung, Andreas und Kahnert, Kathrin (2018): NSCLC Patients Harbouring Rare or Complex EGFR Mutations Are More Often Smokers and Might Not Benefit from First-Line Tyrosine Kinase Inhibitor Therapy. In: Respiration, Bd. 95, Nr. 3: S. 169-176

Jung, Andreas und Kirchner, Thomas (2018): Liquid Biopsy in Tumor Genetic Diagnosis. In: Deutsches Ärzteblatt International, Bd. 115, Nr. 10: S. 169-174

Merk, Daniel J.; Ohli, Jasmin; Merk, Natalie D.; Thatikonda, Venu; Morrissy, Sorana; Schoof, Melanie; Schmid, Susanne N.; Harrison, Luke; Filser, Severin; Ahlfeld, Julia; Erkek, Serap; Raithatha, Kaamini; Andreska, Thomas; Weisshaar, Marc; Launspach, Michael; Neumann, Julia E.; Shakarami, Mehdi; Plenker, Dennis; Marra, Marco A.; Li, Yisu; Mungall, Andrew J.; Moore, Richard A.; Ma, Yussanne; Jones, Steven J. M.; Lutz, Beat; Ertl-Wagner, Birgit; Rossi, Andrea; Wagener, Rabea; Siebert, Reiner; Jung, Andreas; Eberhart, Charles G.; Lach, Boleslaw; Sendtner, Michael; Pfister, Stefan M.; Taylor, Michael D.; Chavez, Lukas; Kool, Marcel und Schüller, Ulrich (2018): Opposing Effects of CREBBP Mutations Govern the Phenotype of Rubinstein-Taybi Syndrome and Adult SHH Medulloblastoma. In: Developmental Cell, Bd. 44, Nr. 6: S. 709-724

Stintzing, Sebastian; Ivanova, Boryana; Ricard, Ingrid; Jung, Andreas; Kirchner, Thomas; Tannapfel, Andrea; Juette, Hendrik; Hegewisch-Becker, Susanna; Arnold, Dirk und Reinacher-Schick, Anke (2018): Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients-Analysis of the Phase III AIO KRK-0207 Trial. In: Frontiers in Oncology, Bd. 8, Nr. 474 [PDF, 1MB]

Lamprecht, Sebastian; Kaller, Markus; Schmidt, Eva Marina; Blaj, Cristina; Schiergens, Tobias S.; Engel, Jutta; Jung, Andreas; Hermeking, Heiko; Grünewald, Thomas G. P.; Kirchner, Thomas und Horst, David (2018): PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer. In: Clinical cancer research, Bd. 24, Nr. 8: S. 1974-1986

Froelich, Matthias F.; Stintzing, Sebastian; Kumbrink, Jörg; Grünewald, Thomas G. P.; Mansmann, Ulrich; Heinemann, Volker; Kirchner, Thomas und Jung, Andreas (2018): The DNA-polymorphism rs849142 is associated with skin toxicity induced by targeted anti-EGFR therapy using cetuximab. In: OncoTarget, Bd. 9, Nr. 54: S. 30279-30288 [PDF, 3MB]

Holch, Julian W.; Ricard, Ingrid; Stintzing, Sebastian; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Scholz, Michael; Müller, Sebastian; Link, Hartmut; Rost, Andreas; Höffkes, Heinz-Gert; Moehler, Markus; Lindig, Reinhard Udo; Miller-Phillips, Lisa; Kirchner, Thomas; Jung, Andreas; Einem, Jobst C. von; Modest, Dominik Paul und Heinemann, Volker (2018): Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial. In: International Journal of Cancer, Bd. 142, Nr. 5: S. 1047-1055

Woischke, Christine; Schaaf, Christian W.; Yang, Hui-Min; Vieth, Michael; Veits, Lothar; Geddert, Helene; Märkl, Bruno; Stömmer, Peter; Schaeffer, David F.; Frölich, Matthias; Blum, Helmut; Vosberg, Sebastian; Greif, Philipp A.; Jung, Andreas; Kirchner, Thomas und Horst, David (2017): In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components. In: Modern Pathology, Bd. 30, Nr. 1: S. 95-103

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; Crispin, Alexander; Schalhorn, Andreas; Stintzing, Sebastian; Giessen-Jung, Clemens; Fischer von Weikersthal, Ludwig; Vehling-Kaiser, Ursula; Stauch, Martina; Quietzsch, Detlef; Holch, Julian W.; Kruger, Stephan; Haas, Michael; Michl, Marlies; Einem, Jobst von; Kirchner, Thomas; Jung, Andreas und Modest, Dominik P. (2017): Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer. In: Anti-cancer drugs, Bd. 28, Nr. 7: S. 717-722 [PDF, 422kB]

Heppt, Markus V.; Siepmann, Timo; Engel, Jutta; Schubert-Fritschle, Gabriele; Eckel, Renate; Mirlach, Laura; Kirchner, Thomas; Jung, Andreas; Gesierich, Anja; Ruzicka, Thomas; Flaig, Michael J. und Berking, Carola (2017): Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care. In: BMC Cancer :17:536: S. 1-12 [PDF, 585kB]

Blaj, Cristina; Bringmann, Agnes; Schmidt, Eva Marina; Urbischek, Manuela; Lamprecht, Sebastian; Fröhlich, Thomas; Arnold, Georg J.; Krebs, Stefan; Blum, Helmut; Hermeking, Heiko; Jung, Andreas; Kirchner, Thomas und Horst, David (2017): ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer. In: Clinical Cancer Research, Bd. 23, Nr. 11: S. 2769-2780

Holch, Julian Walter; Metzeler, Klaus Hans; Jung, Andreas; Riedmann, Kristina; Jost, Philipp Jakob; Weichert, Wilko; Kirchner, Thomas; Heinemann, Volker und Westphalen, Christoph Benedikt (2017): Universal Genomic Testing: The next step in oncological decision-making or a dead end street? In: European Journal of Cancer, Bd. 82: S. 72-79

Bächmann, Sibylle; Ormanns, Steffen; Haas, Michael; Krüger, Stephan; Remold, Anna; Modest, Dominik Paul; Kirchner, Thomas; Jung, Andreas; Werner, Jens; Heinemann, Volker und Böck, Stefan (2017): Switch in KRAS mutational status during an unusual course of disease in a patient with advanced pancreatic adenocarcinoma: implications for translational research. In: BMC Cancer 17:374 [PDF, 614kB]

Holch, Julian Walter; Westphalen, Benedikt; Hiddemann, Wolfgang; Heinemann, Volker; Jung, Andreas und Metzeler, Klaus (2017): Präzisionsonkologie und molekulare Tumorboards – Konzepte, Chancen und Herausforderungen. In: Deutsche Medizinische Wochenschrift, Bd. 142, Nr. 22: S. 1676-1684

Blutke, Andreas; Renner, Simone; Flenkenthaler, Florian; Backman, Mattias; Häsner, Serena; Kemter, Elisabeth; Ländström, Erik; Braun-Reichhart, Christina; Albl, Barbara; Streckel, Elisabeth; Rathkolb, Birgit; Prehn, Cornelia; Palladini, Alessandra; Grzybek, Michal; Krebs, Stefan; Bauersachs, Stefan; Bähr, Andrea; Brühschwein, Andreas

; Deeg, Cornelia A.; Monte, Erica de; Dmochewitz, Michaela; Eberle, Caroline; Emrich, Daniela; Fux, Robert; Groth, Frauke; Gumbert, Sophie; Heitmann, Antonia; Hinrichs, Arne; Kessler, Barbara; Kurome, Mayuko; Leipig-Rudolph, Miriam; Matiasek, Kaspar; Öztürk, Hazal; Otzdorff, Christiane; Reichenbach, Myriam; Reichenbach, Horst Dieter; Rieger, Alexandra; Rieseberg, Birte; Rosati, Marco; Saucedo, Manuel Nicolas; Schleicher, Anna; Schneider, Marlon R.; Simmet, Kilian; Steinmetz, Judith; Übel, Nicole; Zehetmaier, Patrizia; Jung, Andreas; Adamski, Jerzy; Coskun, Ünal; Hrabe de Angelis, Martin; Simmet, Christian; Ritzmann, Mathias; Meyer-Lindenberg, Andrea; Blum, Helmut; Arnold, Georg J.; Fröhlich, Thomas; Wanke, Rüdiger und Wolf, Eckhard (2017): The Munich MIDY Pig Biobank - A unique resource for studying organ crosstalk in diabetes. In: Molecular Metabolism, Bd. 6, Nr. 8: S. 931-940

Bersuch, Eugen; Graef, Florian; Renner, Ellen D.; Jung, Andreas; Traidl-Hoffmann, Claudia; Lauener, Roger und Roduit, Caroline (2017): Lung function improvement and airways inflammation reduction in asthmatic children after a rehabilitation program at moderate altitude. In: Pediatric Allergy and Immunology, Bd. 28, Nr. 8: S. 768-775

Modest, Dominik P.; Stintzing, Sebastian; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Scheithauer, Werner; Kirchner, Thomas; Jung, Andreas; Stauch, Martina; Einem, Jobst Christian von; Möhler, Markus; Held, Swantje und Heinemann, Volker (2017): Relation of early tumor shrinkage (ETS) observed in first-line treatment to efficacy parameters of subsequent treatment in FIRE-3 (AIOKRK0306). In: International Journal of Cancer, Bd. 140, Nr. 8: S. 1918-1925

Blaj, Cristina; Schmidt, Eva Marina; Lamprecht, Sebastian; Hermeking, Heiko; Jung, Andreas; Kirchner, Thomas und Horst, David (2017): Oncogenic Effects of High MAPK Activity in Colorectal Cancer Mark Progenitor Cells and Persist Irrespective of RAS Mutations. In: Cancer Research, Bd. 77, Nr. 7: S. 1763-1774

Haas, Michael; Ormanns, Steffen; Bächmann, Sibylle; Remold, Anna; Krüger, Stephan; Westphalen, Christoph B.; Siveke, Jens T.; Wenzel, Patrick; Schlitter, Anna Melissa; Esposito, Irene; Quietzsch, Detlef; Clemens, Michael R.; Kettner, Erika; Laubender, Rüdiger P.; Jung, Andreas; Kirchner, Thomas; Böck, Stefan und Heinemann, Volker (2017): Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer. In: British Journal of Cancer, Bd. 116, Nr. 11: S. 1462-1469

Lamprecht, Sebastian; Schmidt, Eva Marina; Blaj, Cristina; Hermeking, Heiko; Jung, Andreas; Kirchner, Thomas und Horst, David (2017): Multicolor lineage tracing reveals clonal architecture and dynamics in colon cancer. In: Nature Communications, Bd. 8, 1406 [PDF, 4MB]

Endris, Volker; Stenzinger, Albrecht; Pfarr, Nicole; Penzel, Roland; Möbs, Markus; Lenze, Dido; Darb-Esfahani, Silvia; Hummel, Michael; Merkelbach-Bruse, Sabine; Jung, Andreas; Lehmann, Ulrich; Kreipe, Hans; Kirchner, Thomas; Büttner, Reinhard; Jochum, Wolfram; Höfler, Gerald; Dietel, Manfred; Weichert, Wilko und Schirmacher, Peter (2016): NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial. In: Virchows Archiv, Bd. 468, Nr. 6: S. 697-705

Krieken, J. Han J. M. van; Rouleau, Etienne; Ligtenberg, Marjolijn J. L.; Normanno, Nicola; Patterson, Scott D. und Jung, Andreas (2016): RAS testing in metastatic colorectal cancer: advances in Europe. In: Virchows Archiv, Bd. 468, Nr. 4: S. 383-396

Stintzing, Sebastian; Modest, Dominik P.; Rossius, Lisa; Lerch, Markus M.; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Held, Swantje; Giessen-Jung, Clemens; Moehler, Markus; Jagenburg, Andreas; Kirchner, Thomas; Jung, Andreas und Heinemann, Volker (2016): FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial. In: Lancet Oncology, Bd. 17, Nr. 10: S. 1426-1434

Modest, Dominik Paul; Stintzing, Sebastian; Fischer von Weikersthal, Ludwig; Sobrero, Alberto F.; Decker, Thomas; Kiani, Alexander; Vehling-Kaiser, Ursula; Al-Batran, Salah-Eddin; Heintges, Tobias; Seipelt, Gernot; Lerchenmüller, Christian A.; Kahl, Christoph; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Held, Swantje; Moehler, Markus H.; Jung, Andreas; Kirchner, Thomas und Heinemann, Volker (2016): Time-course evaluation of survival and treatment in FIRE-3 (AIO KRK0306, first-line therapy of KRAS wild-type metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab). In: Journal of Clinical Oncology, Bd. 34, Nr. 4

Stintzing, Sebastian; Modest, Dominik Paul; Jung, Andreas; Kirchner, Thomas; Schäfer, Reinhold; Sers, Christine; Hildebrandt, Bert; Daum, Severin; Folprecht, Gunnar; Schuler, Martin H.; Kasper, Stefan; Trojan, Jorg; Jaeger, Dirk; Schulze-Bergkamen, Henning; Fischer von Weikersthal, Ludwig; Schalhorn, Alexander und Heinemann, Volker (2016): Differences in gene-expression in mCRC tissue samples with regard to tumor location and used chemotherapeutic substances: Data of the FIRE-1 study. In: Journal of Clinical Oncology, Bd. 34, Nr. 4

Griese, Matthias; Zarbock, Ralf; Costabel, Ulrich; Hildebrandt, Jenna; Theegarten, Dirk; Albert, Michael; Thiel, Antonia; Schams, Andrea; Lange, Joanna; Krenke, Katazyrna; Wesselak, Traudl; Schön, Carola; Kappler, Matthias; Blum, Helmut; Krebs, Stefan; Jung, Andreas; Kröner, Carolin; Klein, Christoph; Campo, Ilaria; Luisetti, Maurizio und Bonella, Francesco (2015): GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders. In: BMC Pulmonary Medicine 15:87 [PDF, 1MB]

Zeindl-Eberhart, Evelyn; Brandl, Lydia; Liebmann, Sibylle; Ormanns, Steffen; Scheel, Silvio K.; Brabletz, Thomas; Kirchner, Thomas und Jung, Andreas (2014): Epithelial-Mesenchymal Transition Induces Endoplasmic-Reticulum-Stress Response in Human Colorectal Tumor Cells.
In: PLOS ONE 9(1), e87386 [PDF, 823kB]

Ormanns, Steffen; Siveke, Jens T.; Heinemann, Volker; Haas, Michael; Sipos, Bence; Schlitter, Anna Melissa; Esposito, Irene; Jung, Andreas; Laubender, Rüdiger P.; Kruger, Stephan; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; Fischer von Weikersthal, Ludwig; Clemens, Michael R.; Gauler, Thomas C.; Märten, Angela; Geissler, Michael; Greten, Tim F.; Kirchner, Thomas und Boeck, Stefan (2014): pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104. In: BMC Cancer 14:624 [PDF, 408kB]

Cernat, Laura; Blaj, Cristina; Jackstadt, Rene; Brandl, Lydia; Engel, Jutta; Hermeking, Heiko; Jung, Andreas; Kirchner, Thomas und Horst, David (2014): Colorectal Cancers Mimic Structural Organization of Normal Colonic Crypts.
In: PLOS ONE 9(8), e104284 [PDF, 24MB]

Heinemann, Volker; Vehling-Kaiser, Ursula; Waldschmidt, Dirk; Kettner, Erika; Märten, Angela; Winkelmann, Cornelia; Klein, Stefan; Kojouharoff, Georgi; Gauler, Thomas C.; Fischer von Weikersthal, Ludwig; Clemens, Michael R.; Geissler, Michael; Greten, Tim F.; Hegewisch-Becker, Susanna; Rubanov, Oleg; Baake, Gerold; Höhler, Thomas; Ko, Yon D.; Jung, Andreas; Neugebauer, Sascha und Böck, Stefan (Mai 2013): Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the `Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104). In: Gut, Bd. 62, Nr. 5: S. 751-759 [PDF, 468kB]

Kriegl, Lydia; Jung, Andreas; Horst, David; Rizzani, Antonia; Jackstadt, Rene; Hermeking, Heiko; Gallmeier, Eike; Gerbes, Alexander L.; Kirchner, Thomas; Göke, Burkhard und De Toni, Enrico N. (2012): Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer.
In: PLOS ONE 7(12), e51654 [PDF, 646kB]

Modest, Dominik P.; Brodowicz, Thomas; Stintzing, Sebastian; Jung, Andreas; Neumann, Jens; Laubender, Ruediger P.; Ocvirk, Janja; Kurteva, Galina; Papai, Zsuzsanna; Knittelfelder, Regina; Kirchner, Thomas; Heinemann, Volker und Zielinski, Christoph C. (2012): Impact of the Specific Mutation in KRAS Codon 12 Mutated Tumors on Treatment Efficacy in Patients with Metastatic Colorectal Cancer Receiving Cetuximab-Based First-Line Therapy: A Pooled Analysis of Three Trials. In: Oncology, Nr. 5: S. 241-247 [PDF, 200kB]

Neumann, Jens; Bahr, Fiorina; Horst, David; Kriegl, Lydia; Engel, Jutta; Luque, Raquel Mejias; Gerhard, Markus; Kirchner, Thomas und Jung, Andreas (2011): SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. In: BMC Cancer 11:518 [PDF, 4MB]

Scheel, Silvio K.; Porzner, Marc; Pfeiffer, Sabine; Ormanns, Steffen; Kirchner, Thomas und Jung, Andreas (2010): Mutations in the WTX - gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers. In: BMC Cancer 10:413 [PDF, 701kB]

Kriegl, Lydia; Horst, David; Reiche, Jana A.; Engel, Jutta; Kirchner, Thomas und Jung, Andreas (2010): LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer. In: Journal of Translational Medicine 8:123 [PDF, 1MB]

Diese Liste wurde am Sat Apr 13 23:11:19 2024 CEST erstellt.

Exportieren als	RSS 1.0 RSS 2.0